Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000173809 | SCV000224961 | benign | not specified | 2014-07-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000173809 | SCV000514389 | likely benign | not specified | 2017-03-28 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genetic Services Laboratory, |
RCV000173809 | SCV000596748 | likely benign | not specified | 2016-01-05 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000545530 | SCV000656371 | benign | Norman-Roberts syndrome; Familial temporal lobe epilepsy 7 | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003965250 | SCV004792347 | benign | RELN-related condition | 2019-05-02 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Genome Diagnostics Laboratory, |
RCV001701777 | SCV001929355 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001701777 | SCV001973681 | likely benign | not provided | no assertion criteria provided | clinical testing |